Position in IQV
as of Jun 30, 2026
· filed Jul 15, 2026
Position Value
$602,073
+$291,350 QoQ
Shares Held
3,116
+71.0% QoQ
Ownership
0.002%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
#602
of 1,077 holders
Holding Since
Jun 2025
5 quarters on record
Voting authority
Sole 5%
Shared 0%
None 95%
Common Shares in IQV Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Jun 30, 2026NorthCrest Asset Manangement, LLC holds $36,393,398 across 13 Diagnostics & Research names. IQV ranks #7 (1.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | TMO |
Thermo Fisher Scientific Inc.
|
40,344 | $20,226,867 | |
| 2 | LH |
Labcorp Holdings Inc.
|
31,591 | $8,845,480 | |
| 3 | ILMN |
Illumina, Inc.
|
8,137 | $1,430,728 | |
| 4 | NTRA |
Natera, Inc.
|
5,160 | $1,400,682 | |
| 5 | A |
Agilent Technologies, Inc.
|
7,093 | $942,163 | |
| 6 | DHR |
Danaher Corp /De/
|
3,400 | $647,632 | |
| 7 | IQV |
Iqvia Holdings Inc.
This page
|
3,116 | $602,073 | |
| 8 | RVTY |
Revvity, Inc.
|
5,103 | $567,759 |
All Filings in IQV
Export CSV
5 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $602,073 | 3,116 | Shares | Sole | 2026-07-15 | |
| 2026-03-31 | $310,723 | 1,822 | Shares | Sole | 2026-04-08 | |
| 2025-12-31 | $909,754 | 4,036 | Shares | Sole | 2026-01-08 | |
| 2025-09-30 | $459,844 | 2,421 | Shares | Sole | 2025-10-29 | |
| 2025-06-30 | $197,302 | 1,252 | Shares | Sole | 2025-07-10 | |
| No filing history on record for this holder in this stock. | ||||||